BBHC
TAK icon

Brown Brothers Harriman & Co’s Takeda Pharmaceutical TAK Stock Holding History

Brown Brothers Harriman & Co’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
9,333
+2,521
+37% +$41.7K ﹤0.01% 920
2026
Q1 		$126K Buy
6,812
+5,900
+647% +$104K ﹤0.01% 890
2025
Q4 		$14.2K Buy
912
+885
+3,278% +$12.7K ﹤0.01% 1271
2025
Q3 		$395 Sell
27
-286
-91% -$4.25K ﹤0.01% 1653
2025
Q2 		$4.84K Buy
+313
New +$4.63K ﹤0.01% 1277
2022
Q4 		– Sell
-1,271
Closed -$16K – 1489
2022
Q3 		$16K Buy
1,271
+286
+29% +$3.98K ﹤0.01% 1041
2022
Q2 		$14K Sell
985
-6,331
-87% -$90.4K ﹤0.01% 958
2022
Q1 		$105K Buy
+7,316
New +$107K ﹤0.01% 625
2021
Q3 		– Sell
-1,518
Closed -$26K – 1222
2021
Q2 		$26K Buy
1,518
+503
+50% +$8.56K ﹤0.01% 772
2021
Q1 		$19K Sell
1,015
-123
-11% -$2.21K ﹤0.01% 779
2020
Q4 		$21K Hold
1,138
– – ﹤0.01% 780
2020
Q3 		$20K Hold
1,138
– – ﹤0.01% 697
2020
Q2 		$20K Sell
1,138
-109
-9% -$1.96K ﹤0.01% 687
2020
Q1 		$19K Buy
+1,247
New +$22.6K ﹤0.01% 638
2019
Q4 		– Sell
-372
Closed -$6K – 1272
2019
Q3 		$6K Buy
+372
New +$6.43K ﹤0.01% 966
2019
Q2 		– Sell
-129
Closed -$3K – 1219
2019
Q1 		$3K Buy
129
+100
+345% +$2.01K ﹤0.01% 941
2018
Q4 		$0 Buy
+29
New +$490 ﹤0.01% 987

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Brown Brothers Harriman & Co's TAK Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Takeda Pharmaceutical (TAK) stake by 37% in Q2 2026, buying an estimated $41.7K and bringing the position to 9,333 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #920.

Brown Brothers Harriman & Co first reported a position in TAK in Q4 2018 and has held it in 17 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Brown Brothers Harriman & Co held 9,333 shares of Takeda Pharmaceutical worth $150K as of Q2 2026.
  • Brown Brothers Harriman & Co bought 2,521 Takeda Pharmaceutical shares in Q2 2026, an estimated $41.7K.
  • Takeda Pharmaceutical made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #920 holding.
  • Brown Brothers Harriman & Co first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 17 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.